Abstracts Archive - Page 1908 of 2425 - ACR Meeting Abstracts

Abstract Number: 2152 • 2014 ACR/ARHP Annual Meeting
Frequency of Postoperative Deep Infection in Patients with Rheumatoid Arthritis
Masayuki Azukizawa and Hiromu Ito, Orthopaedic surgery, Kyoto University, Kyoto, Japan
Background/Purpose: Rheumatoid arthritis (RA) is known to be associated with an increased risk of serious infection. It has been discussed about the risk of the…
Abstract Number: 2153 • 2014 ACR/ARHP Annual Meeting
Clinical Characteristics and Outcomes in Synovial Fluid Culture ̵ Negative Septic Arthritis
Sarah B. Lieber, Ziv Paz and Robert H. Shmerling, Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: Delays in diagnosis and treatment of septic arthritis may be associated with significant morbidity. While many patients with suspected or proven septic arthritis are…
Abstract Number: 2154 • 2014 ACR/ARHP Annual Meeting
Risk for Developing Adult T-Cell Leukemia in Patients with Human T Lymphotropic Virus Type-I Carrier Receiving Immunosuppressive Therapy
Kensuke Nakanishi¹, Rita Mcgill² and Mitsuyo Kinjo¹, ¹Internal Medicine, Okinawa Chubu Hospital, Uruma City Okinawa, Japan, ²Nephrology, AGH Nephrology Associates, Pittsburgh, PA
Background/Purpose: Human T-lymphotropic virus type-I (HTLV-1) is a retrovirus associated with Adult T-cell leukemia (ATL) that is commonly seen in endemic areas. Several case reports…
Abstract Number: 2155 • 2014 ACR/ARHP Annual Meeting
Chikungunya Fever in Patients Under Biologics
Lauren Brunier¹, Katleen Polomat², Christophe Deligny², Veronique Dehlinger³, Patrick Numeric⁴, Georges Jean-Baptiste³, Serge Arfi² and Michel De Bandt⁵, ¹CHUM de Martinique,, Unit of rheumatology, CHUM, 97200 Fort de France, France, ²CHUM de Martinique,, unit of internal medicine, Fort de France, France, ³CHUM de Martinique,, Unit of rheumatology, CHUM, Fort de France, France, ⁴route de Chateauboeuf, 97200; French West Indies, Unit of rheumatology, CHUM, Fort de France, France, ⁵Rheumatology, Hopital Zobda-Quitman. CHU La Meynard., Fort de FRance, France
Background/Purpose Chick is an epidemic disease due to an arthropod-borne virus (Alphavirus) transmitted by Aedes mosquitoes. CHIKV causes an acute illness with a febrile phase,…
Abstract Number: 2156 • 2014 ACR/ARHP Annual Meeting
Persistent Arthralgia Following Chikungunya Fever
Anna Kristina Gutierrez-Rubio and Ester Penserga, Section of Rheumatology, Philippine General Hospital, Manila, Philippines
Background/Purpose: Chikungunya fever is a reemerging viral infection in the Philippines and neighboring countries. Persistent arthralgia following Chikungunya infection has been observed during previous epidemics,…
Abstract Number: 2157 • 2014 ACR/ARHP Annual Meeting
Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases
Bunyamin Kisacik¹, Omer Pamuk², Ahmet Mesut Onat³, B. Erer⁴, Gulen Hatemi⁵, Yesim Ozguler⁶, Yavuz Pehlivan⁷, Levent Kilic⁸, Ihsan Ertenli⁸, Meryem Can⁹, Haner Direskeneli⁹, Gökhan Keser¹⁰, Fahrettin Oksel¹⁰, Ediz Dalkilic¹¹, Sedat Yilmaz¹², Salih Pay¹³, Ayse Balkarli¹⁴, Veli Cobankara¹⁵, Gozde Yildirim Cetin¹⁶, Mehmet Sayarlioglu¹⁷, Ayse Cefle¹⁸, Ayten Yazici¹⁸, Ali Berkant Avci¹⁹, Ender Terzioglu²⁰, Suleyman Ozbek²¹, Servet Akar²² and Ahmet Gül²³, ¹Rheumatology, Gaziantep University, School of Medicine, Gaziantep, Turkey, ²Trakya Üniversitesi, edirne, Turkey, ³Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁴Istanbul Faculty of Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ⁵Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, ⁶University of Istanbul, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, ⁷Rheumatology, Uludag University, School of Medicine, Bursa, Turkey, ⁸Hacettepe Üniversity, Ankara, Turkey, ⁹Marmara Üniversitesi, Ýstanbul, Turkey, ¹⁰Ege Üniversitesi, Ýzmir, Turkey, ¹¹Uludað Üniversitesi, Bursa, Turkey, ¹²GATA, ANKARA, Turkey, ¹³GATA, Ankara, Turkey, ¹⁴Pamukkale Üniversitesi, Denizli, Turkey, ¹⁵Denizli Üniversitesi, Denizli, Turkey, ¹⁶Deparment of Rheumatology, Sutcu Imam University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey, ¹⁷Rheumatology, Ondokuz Mayis University School of Medicine, Samsun, Turkey, ¹⁸Department of Rheumatology, Kocaeli University, Kocaeli, Turkey, ¹⁹Antalya University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Antalya, Turkey, ²⁰School of Medicine, Akdeniz University, Antalya, Turkey, ²¹Cukurova Üniversitesi, Adana, Turkey, ²²Katip Çelebi Üniversitesi, Ýzmir, Turkey, ²³Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Background/Purpose Tumor necrosis factor alpha inhibitors (anti-TNF) are a breakthrough for the treatment of inflammatory rheumatic diseases and tuberculosis (TB) is the prevailing and vitally…
Abstract Number: 2158 • 2014 ACR/ARHP Annual Meeting
Severe Neutropenia in Patients with Rheumatic Diseases at a Tertiary Care Hospital in South Korea
Chang-Nam Son¹, Ji-Min Kim¹, Sang-Hyon Kim¹, Soo-Kyung Cho², Yoon-Kyoung Sung², Tae-Hwan Kim³, Jae-Bum Jun², Sang-Cheol Bae⁴ and Dae-Hyun Yoo⁴, ¹Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea, ²Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ³Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁴Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea
Background/Purpose: Neutropenia is relatively common in patients with rheumatic diseases. Neutropenia is characterized by an absolute neutrophil count (ANC) of less than 1,500/µL. It is…
Abstract Number: 2159 • 2014 ACR/ARHP Annual Meeting
Human T-Lymphotropic Virus Type 1 Biomarkers in Patients with Rheumatoid Arthritis
Akihiko Okayama¹, Masako Iwanaga², Yasuko Sagara³, Toshihiko Hidaka⁴, Kunihiko Umekita⁵, Kazumi Nakano⁶, Toshiki Watanabe⁶, Yoshihisa Yamano⁷, Yoshiro Horai⁸, Hideki Nakamura⁹ and Atsushi Kawakami⁹, ¹Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan, ²The Jikei University of School of Medicine, Tokyo, Japan, ³Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan, ⁴Zenjinkai Shimin-No-Mori Hospital, Miyazaki, Japan, ⁵University of Miyazaki, Miyazaki, Japan, ⁶Laboratory of Tumor Cell Biology, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan, ⁷Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan, ⁸Departments of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, ⁹Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Background/Purpose: Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL). It has been debated recently whether or not immunosuppressive…
Abstract Number: 2161 • 2014 ACR/ARHP Annual Meeting
Interest of Systematic Lyme Serology in Context of Recent Onset Arthritis
Dewi Guellec¹, Valérie Narbonne², Divi Cornec³, Thierry Marhadour⁴, Maxime Dougados⁵, Jean-Pierre Daures⁶, Sandrine Jousse-Joulin¹, Valerie Devauchelle⁷ and Alain Saraux⁸, ¹Rheumatology, CHU Brest, Brest, France, ²Microbiology, CHU Brest, Brest, France, ³Department of rheumatology and unit of immunology, Brest Occidentale University, Brest, France, ⁴Rheumatology, CHU de la Cavale Blanche, Brest, France, ⁵INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France, ⁶Biostatistic, INSERM, Montpellier, France, ⁷Rheumatology, Brest university medical school, EA 2216, Lab Ex, INSERM, IGO,UBO and CHU de la Cavale Blanche,, Brest, France, ⁸Rhumatologie, CHU Brest and EA 2216, UBO, Brest, France
Background/Purpose Lyme arthritis is a late manifestation of a tick-transmitted spirotechal infection, mainly caused by Borrelia burdorgferi. Lyme arthritis typically presents as a mono- or…
Abstract Number: 2162 • 2014 ACR/ARHP Annual Meeting
Immunological Abnormalities in Adult Patients with Parvovirus B19 Infection : A study of 23 Cases
Edouard Pertuiset, Farid Kemiche, Mehdi Yahia and Isabelle Cerf-Payrastre, Rheumatology, Centre Hospitalier René Dubos, Pontoise, France
Background/Purpose In adults, parvovirus B19 infection can induce joint symptoms and cutaneous manifestations which are known to be transient most of the time. It has…
Abstract Number: 2163 • 2014 ACR/ARHP Annual Meeting
Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF)
Gaetane Nocturne¹, Saida Boudaoud², Caroline Besson³, Frederic Davi⁴, Danielle Canioni⁵, Patrice Cacoub⁶, Olivier Hermine⁷ and Xavier Mariette⁸, ¹INSERM U1012, Paris sud university, Le Kremlin Bicetre, France, ²Université Paris-Sud, INSERM U1012, Le Kremlin Bicêtre, France, ³Paris Sud University, Le Kremlin Bicêtre, France, ⁴Department of Pathology, Hôpital de la Pitié Salepetrière, Paris, France, ⁵Service d'anatomo-pathologie, Hôpital Necker,, Paris, France, ⁶Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, ⁷Service d'hématologie, Centre de référence des mastocytoses, Hôpital Necker Enfants malades, Université Paris V, IFR Necker,, Paris, France, ⁸rheumatology, Université Paris-Sud, Le Kremlin Bicêtre, France
Background/Purpose: HCV chronic infection is associated with an increased risk of non-Hodgkin lymphoma (NHL) occurrence. HCV-associated NHL share homologies with primary Sjögren Syndrome (pSS)-associated NHL,…
Abstract Number: 2164 • 2014 ACR/ARHP Annual Meeting
Self-Phospholipids Regulate Inflammation Via Activation of CD1d-Restricted T-cells and Induction of ‘anti-inflammatory’ Myeloid-Derived Suppressor Cells (MDSC)
Ram Raj Singh^1,2,3,4, Cynthia Tran¹, Priti Prasad¹, Jing Wang⁵, Dirk Zajonc⁵ and Ramesh Halder¹, ¹Autoimmunity and Tolerance Laboratory, Department of Medicine/Rheumatology, UCLA, Los Angeles, CA, ²Interdepartmental Program in Molecular Toxicology, UCLA, Los Angeles, CA, ³Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, ⁴Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, CA, ⁵La Jolla Institute of Allergy and Immunology, La Jolla, CA
Background/Purpose Self-lipids play an increasingly appreciated role in immunity and inflammation. Lipid antigens are presented by CD1d and CD1a-d molecules in mouse and human, respectively,…
Abstract Number: 2165 • 2014 ACR/ARHP Annual Meeting
Myeloid-Derived Suppressor Cells in Rheumatoid Arthritis: Friend or Foe?
Fanlei Hu¹, Chunqing Guo², Xiang-Yang Wang² and Zhanguo Li¹, ¹Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, ²Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA
Background/Purpose Although myeloid-derived suppressor cells (MDSCs) have been linked to T-cell tolerance, their role in rheumatoid arthritis (RA) remains exclusive. Here, we investigated the potential…
Abstract Number: 2166 • 2014 ACR/ARHP Annual Meeting
Bim Suppresses the Development of Glomerulonephritis By Inhibiting M2 Polarization
Fu-Nien Tsai, Northwestern University, Chicago, IL
Background/Purpose Only recently have monocytes and macrophages been accepted as critical players in the pathogenesis of SLE. However, very little is known regarding the molecular…
Abstract Number: 2167 • 2014 ACR/ARHP Annual Meeting
Snapin Is Critical for Cathepsin D Activation and the Normal Lysosomal Function
Bo Shi¹, Qi Quan Huang², Robert Birkett², Renee E. Koessler¹, Andrea Dorfleutner¹, Christian Stehlik¹ and Richard M. Pope¹, ¹Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, ²Medicine/Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL
Background/Purpose: Our recent data indicates that Snapin, a SNAP associated protein, is critical for maintaining healthy autophagy and monocytes to macrophage (MFs) differentiation which requires…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].